Livzon Pharmaceutical Group Inc. (FRA:LP6)

FRA:LP6 Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Jan 1, 2021
Market Capitalization	3,614	4,063	3,610	3,725	4,472	4,158
Market Cap Growth	-8.65%	12.56%	-3.09%	-16.70%	7.54%	16.92%
Enterprise Value	2,918	3,278	2,896	3,025	3,753	3,397
Last Close Price	3.32	3.17	2.41	2.57	2.45	2.27
PE Ratio	14.09	14.90	14.48	14.38	18.19	19.33
PS Ratio	2.55	2.60	2.28	2.17	2.68	3.15
PB Ratio	1.96	2.06	1.92	1.84	2.26	2.43
P/TBV Ratio	2.26	2.30	2.10	2.08	2.56	2.82
P/FCF Ratio	11.90	12.75	11.65	14.98	54.46	21.90
P/OCF Ratio	9.45	10.31	8.71	9.90	16.98	15.35
EV/Sales Ratio	2.03	2.10	1.83	1.77	2.25	2.58
EV/EBITDA Ratio	8.30	8.03	8.28	8.70	11.58	11.19
EV/EBIT Ratio	9.51	9.77	11.81	11.54	14.14	13.35
EV/FCF Ratio	9.61	10.29	9.35	12.17	45.71	17.89
Debt / Equity Ratio	0.26	0.27	0.28	0.24	0.19	0.14
Debt / EBITDA Ratio	1.36	1.28	1.50	1.40	1.14	0.80
Debt / FCF Ratio	1.55	1.65	1.71	1.98	4.54	1.27
Asset Turnover	0.48	0.48	0.50	0.54	0.56	0.55
Inventory Turnover	2.31	2.09	2.33	2.47	2.74	2.82
Quick Ratio	1.95	1.87	1.86	1.97	1.83	2.13
Current Ratio	2.25	2.15	2.13	2.30	2.12	2.40
Return on Equity (ROE)	16.43%	15.53%	12.78%	13.37%	13.97%	16.45%
Return on Assets (ROA)	6.38%	6.40%	4.81%	5.11%	5.58%	6.58%
Return on Capital (ROIC)	8.23%	8.39%	6.41%	6.79%	7.36%	8.69%
Return on Capital Employed (ROCE)	14.70%	15.10%	11.30%	11.10%	12.40%	14.00%
Earnings Yield	7.10%	6.71%	6.91%	6.95%	5.50%	5.17%
FCF Yield	8.40%	7.85%	8.58%	6.67%	1.84%	4.57%
Dividend Yield	4.02%	4.58%	7.16%	8.44%	7.36%	6.89%
Payout Ratio	48.57%	65.03%	81.36%	83.33%	70.81%	64.14%
Buyback Yield / Dilution	2.91%	1.10%	0.56%	0.04%	0.25%	-0.41%
Total Shareholder Return	6.93%	5.69%	7.72%	8.48%	7.61%	6.49%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.